Aurobindo Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 10, 2025. Further, the company has informed the Exchange regarding voting results.
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aurobindo Pharma has submitted the Scrutinizer's report and voting results of its Annual General Meeting (AGM) held on September 10, 2025, to the stock exchange. This is a standard post-AGM regulatory filing that discloses how shareholders voted on various resolutions tabled at the meeting. The filing confirms that the company has completed the procedural compliance required after conducting its AGM. No specific resolution outcomes or voting percentages are mentioned in the announcement.
This is a routine compliance filing with no direct impact on share price. Investors should review the detailed voting results to understand shareholder sentiment on key resolutions such as financial statements, director appointments, and any special business.